Ovid Therapeutics Inc. (OVID) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Ovid Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$2.45
+8.41% today
Market cap
$441M
Overall quality
—
Kronos AI 30-day
+13.4%
7 of 8 simulated paths end higher
Ovid Therapeutics Inc. (OVID) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $441M. It trades at $2.45, up 8.41% today. 10 analysts' average target of $6.50 implies +165.3% from today's price. Kronos AI's 30-day forecast is +13.4% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $6.50 |
| Low – high | $5.00 – $9.00 |
| Analysts | 10 |
| Upside to average | +165.3% |
Kronos AI 30-day forecast
| Expected close | $2.56 (+13.4%) |
| Likely range | +6.5% … +16.5% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.